Acadia Pharmaceutica (ACAD)
$16.31
0.28 (1.69%)
ACAD Stock Quote Delayed 30 Minutes
Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout
Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn't get too excited yet.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.65B
PE Ratio
-30.77
EPS
-0.53
Volume (Avg. Vol.)
1.66M
Day's Range
$16.16 - $16.51
52-Week Range
$16.16 - $33.99
Dividend & Yield
N/A (N/A)
ACAD Stock Predictions, Articles, and Acadia Pharmaceutica News
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
41 Biotechnology Stocks to Sell Now
The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – XNY PGNX AVXS QBAK
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over the Next Year
ACAD may have a rocky year ahead, but long-term any losses or shortcomings for Acadia will prove to be an excellent investment opportunity.
Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD
Acadia Pharmaceuticals likely has many interested buyers on the line for its drug Nuplazid, which is good news for ACAD stock.
Hottest Manufacturing Stocks Now – WKHS TPUB PTI NR
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – MLSS VBLT SBBP BSTG
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
3 Stocks to Watch on Monday: Acadia Pharmaceuticals Inc. (ACAD), Caterpillar Inc. (CAT) and Tesla Motors Inc (TSLA)
Acadia Pharmaceuticals (ACAD) gets an FDA green light for Nuplazid, Caterpillar (CAT) is closing a number of plants over lowered demand and Tesla Motors (TSLA) is bringing Ludicrous Mode to the masses.
Biotech Stocks That Could Double in 2016: Acadia Pharmaceuticals (ACAD)
ACAD stock may look expensive, but it's still going to double next year thanks to a new drug with a Breakout Therapy designation.
GILD Stock: What Investors Really Want to See From Q3
Gilead Science's Q3 numbers aren't as important to GILD stock compared to what it does to solidify the future.
Hottest Healthcare Stocks Now – MYGN VRX IRWD XRAY
Healthcare stocks declined on Wall Street on Tuesday, down 2.4%.
